[{"Assets_0_Q2_USD":13173600000.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_2_Q2_USD":1085300000.0,"NetIncomeLossConverted_1_Q2_USD":193100000.0,"NetIncomeLossConverted_2_Q2_USD":654200000.0,"StockholdersEquity_0_Q2_USD":9755900000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":114600000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":115000000.0,"EarningsPerShareBasic_1_Q2_USD":1.77,"EarningsPerShareBasic_2_Q2_USD":6.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":109200000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":109100000.0,"EarningsPerShareDiluted_1_Q2_USD":1.68,"EarningsPerShareDiluted_2_Q2_USD":5.69,"RevenuesConverted_1_Q2_USD":1933700000.0,"RevenuesConverted_2_Q2_USD":3645500000.0,"Ticker":"REGN","CIK":"872589","name":"REGENERON PHARMACEUTICALS, INC.","OfficialName":"Regeneron Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20190630","fy":"2019.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"77738004554.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"SP500","filed":"20190806"}]